New Skin-Tightening device tested on diverse skin types and Weight-Loss drug users
NCT ID NCT07224880
First seen Nov 05, 2025 · Last updated May 17, 2026 · Updated 28 times
Summary
This study is testing a device called Ellacor that uses tiny needles to remove small pieces of skin, aiming to reduce wrinkles and tighten loose skin on the face and belly. It includes people with a wide range of skin types (light to dark) and those taking GLP-1 medications (like Ozempic) for weight loss. Researchers will check for side effects and take photos to measure changes over 90 days. Only 10 adults aged 30-65 with moderate to severe wrinkles and belly skin looseness can join.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLP1 AGONIST are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tri Valley Plastic Surgery
RECRUITINGDublin, California, 94568, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.